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Abstract
Background: Cardiovascular disease and its risk factors have consistently been
associated with poor cognitive function and incident dementia. Whether
cardiovascular disease prediction models, developed to predict an individual’s risk
of future cardiovascular disease or stroke, are also informative for predicting risk of
cognitive decline and dementia is not known.
Objective: The objective of this systematic review was to compare cohort studies
examining the association between cardiovascular disease risk models and
longitudinal changes in cognitive function or risk of incident cognitive impairment or
dementia.
Materials and Methods: Medline, PsychINFO, and Embase were searched from
inception to March 28, 2014. From 3,413 records initially screened, 21 were
included.
Results: The association between numerous different cardiovascular disease risk
models and cognitive outcomes has been tested, including Framingham and non-
Framingham risk models. Five studies examined dementia as an outcome; fourteen
studies examined cognitive decline or incident cognitive impairment as an outcome;
and two studies examined both dementia and cognitive changes as outcomes. In all
studies, higher cardiovascular disease risk scores were associated with cognitive
changes or risk of dementia. Only four studies reported model prognostic
performance indices, such as Area Under the Curve (AUC), for predicting incident
dementia or cognitive impairment and these studies all examined non-Framingham
Risk models (AUC range: 0.74 to 0.78).
Conclusions: Cardiovascular risk prediction models are associated with cognitive
changes over time and risk of dementia. Such models are easily obtainable in
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clinical and research settings and may be useful for identifying individuals at high
risk of future cognitive decline and dementia.
Introduction
Modification of health and lifestyle factors could improve vascular heath and
possibly reduce the risk of cognitive decline and dementia [1]. Indeed,
modification of health and lifestyle factors such as, diabetes, hypertension, obesity,
physical inactivity, depression, smoking and low education levels, could result in
an 8.3% reduction in the prevalence of Alzheimer’s Disease (AD) by 2050 [1].
Given that cardiovascular risk factors often co-occur, several models have been
developed to predict an individuals’ risk of future cardiovascular disease (CVD)
or stroke based on combinations of risk factors [2]. The most widely used in
research and clinical settings are the Framingham risk models for predicting 10-
year incident stroke, coronary heart disease (CHD) and general CVD [3]. These
models usually incorporate cholesterol and blood pressure (BP) with a number of
different additional variables such as age, smoking status, and ECG measures of
heart health. These models generally have reasonable predictive accuracy for CVD
events [2].
In older populations health-related co-morbidities are highly prevalent.
Therefore, the investigation of the effect of multiple cardiovascular and health-
related risk factors on cognitive function may be more relevant to real populations
rather than examining individual risk factors in isolation. Further, the association
between individual cardiovascular risk factors and cognitive function has been
extensively studied [4–6]. With regards to combinations of risk factors, several
population-based longitudinal studies have found different cardiovascular risk
models to be associated with cognitive decline, including measures of global and
domain specific (e.g., memory and non-memory) cognitive function [7–9]. For
the purpose of specifically predicting later-life dementia, the Cardiovascular Risk
Factors, Aging and Dementia (CAIDE) model, incorporating demographic
variables (e.g., age, sex, education), midlife CVD risk factors (e.g., total
cholesterol, systolic BP, body-mass index (BMI), physical activity) and/or
Apolipoprotein E4 (ApoE4) status, was developed. This model has reasonable
accuracy for predicting dementia [10, 11]. Given that numerous different CVD
risk prediction models exist and a number of these have been tested within a
dementia framework, evidence on comparisons is needed.
Accordingly, the aim of this systematic review was to synthesise evidence, from
population-based studies, on the link between CVD risk prediction models on one
hand, and longitudinal changes in cognition (e.g., global and domain specific) and
risk of incident dementia on the other hand. Knowledge of the association of CVD
risk models with cognitive outcomes is important for identifying individuals at
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high-risk of dementia whose risk could possibly be mitigated through manage-
ment of risk factors or primary prevention strategies focused on CVD.
Materials and Methods
Selection criteria and search strategy
This review was undertaken in accordance with the PRISMA statement [12].
Medline, PsychINFO and Embase were searched from inception until March 28,
2014. Combinations of the following terms were searched: ‘‘cognit*’’, ‘‘dementia’’,
‘‘Alzheimer’’, ‘‘Framingham’’, ‘‘QRISK’’, ‘‘CAIDE’’, ‘‘ASSIGN’’, ‘‘vascular risk’’,
‘‘cardiovascular risk’’, ‘‘stroke risk’’ and ‘‘cardiovascular health’’. The search was
restricted to articles published in English. One author completed the electronic
search (SLH). Articles were included into the review based on the following
criteria: 1) examined cardiovascular or stroke risk assessment models; 2) details of
cognitive test scores (or change scores) were available at two or more time points
or dementia incidence over time was reported; and, 3) longitudinal population-
based study design. Articles were excluded if they only looked at individual risk
factors, had a cross-sectional study design, or if they included cognitive test results
in the risk model. Studies were not excluded based on the type of cardiovascular
risk model or the neuropsychological test battery used to assess cognitive function.
There was no restriction on sample age. Two authors (SLH and JD) first
independently searched the article titles and abstracts. When a title/abstract of a
study could not be rejected with certainty, the full text of the article was obtained
for further investigation. The full text articles were then retrieved and assessed for
eligibility. Relevant reviews were also retained and the reference lists of these and
each included paper were reviewed for any missed articles. Any discrepancies
between the selections made were resolved by consensus or by asking a third
investigator (BCMS).
Data extraction
Data were independently extracted by two authors (SLH and EYHT) including:
date of publication, participants (country, follow-up assessment time), demo-
graphics (age and gender distributions), details of the risk model used and any
modifications made, the main outcome measure (e.g., neuropsychological test or
dementia incidence), analytical strategy (including multivariate adjustments) and
(where reported) details on model prognostic performance including sensitivity,
specificity, Area Under the Curve (AUC) or c-statistic. Discrepancies between data
extraction results were resolved by reviewing the discrepancy. One investigator
(SLH) assessed the quality of the included studies using the Newcastle-Ottawa
Scale (NOS) for quality assessment of non-randomized studies, specifically cohort
studies [13], as endorsed by the Cochrane collaboration [14]. The NOS uses a star
rating system to assess selection, comparability and outcome criteria, with a
maximum possible score of nine stars for each study.
Cardiovascular Risk Models and Cognition: A Systematic Review
PLOS ONE | DOI:10.1371/journal.pone.0114431 December 5, 2014 3 / 14
Results
Main Search
The search identified 6,500 publications, of which 3,087 were duplicates and
therefore removed. After reviewing titles/abstracts for eligibility, 90 publications
were retained for full-text review. In total, 21 publications met the inclusion
criteria and were retained. The main reasons for exclusion were that the articles
were reviews or they examined individual cardiovascular risk factors, rather than
using a cardiovascular disease risk model (Figure 1). It was not possible to
conduct a meta-analysis due to the variability between studies including
differences in inclusion of variables within the same risk models, limited number
of studies using the same models, differences in cognitive outcomes, categorisa-
tion of the risk models (i.e., categorical or continuous) and differences in
reporting the effect sizes.
Study Characteristics
Table 1 shows a summary of the included studies and Tables S1, S2 and S3 show
further details (online only). Three of the included studies were conducted with
the Whitehall II study population [7, 9, 15], and two used the Reasons for
Geographic and Racial Differences in Stroke (REGARDS) study data [16, 17].
Mean age at baseline ranged from 42.0 to 81.5 years, although three studies did
not report the mean age for all participants [18–20]. Length of follow-up ranged
from 2 to 36 years. The Canadian Study of Health and Aging had the smallest
follow-up sample size of 223 participants [19], whereas, the REGARDS study had
the largest follow-up sample size of .23,000 participants [16, 17].
Quality of the included studies
Articles were assessed on selection, comparability and outcome. The majority of
studies showed a low risk of selection bias (n519 used clinical examinations and
medical records to ascertain the variables required for the cardiovascular risk
models, and only two studies based this on self-report). Most studies (n520) were
defined as representative of the general older population, but one study [21]
demonstrated bias as it only included males. Adjustment for confounding factors
varied widely. All studies used an established cognitive test or validated dementia
criteria as the outcome. However, many different cognitive tests were used raising
issues of comparability across the studies. Loss to follow-up was high; 20 studies
had a follow-up rate ,80% or made no statement about loss to follow-up.
The different risk models and dementia
Seven studies examined seven different risk models with dementia as the outcome
including: the Framingham CVD model [22], the CAIDE model (three studies:
one study used CAIDE model 1 [11], one study used CAIDE model 2 (with ApoE4
status included) [23] and one study examined both CAIDE models [10]), the
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vascularity index model [19], the vascular index [24], the atherosclerotic risk
profile [25], the hypoperfusion risk profile [25] and a cardiovascular composite
model [26]. In one study the outcome was incident AD [19] and in the remaining
studies the outcome was incident dementia (all-cause) [10, 11, 23–26].
All studies, except one [19], found the different risk models to be significantly
associated with an increased risk of future dementia. In the study that showed
non-significant results, a vascular index incorporating history of stroke, transient
ischaemic attack, heart attack, diabetes mellitus, smoking, use of antihypertensive
medications and systolic BP was not associated with risk of AD over five years in a
population-based sample aged 65 years and older. However, the vascular index
model was found to be associated with an increased risk of vascular cognitive
impairment (VCI) [19].
Where model prognostic performance indices were reported findings were
mixed [10, 11, 19, 24]. Two studies reported moderate prognostic performance for
the CAIDE models dementia (AUC 0.77 (model 1) and 0.78 (model 2) over 20
Figure 1. PRISMA flow chart diagram of the literature search.
doi:10.1371/journal.pone.0114431.g001
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Table 1. Summary of the articles included in the review.
Author Follow- up sample (sex) Outcome Follow-up (yrs) Baseline age (yrs) CV risk model
Quality
(Newcastle-
Ottawa Scale)
Studies examining the Framingham risk models
Brady (2001) 235 (all men) Change in cog-
nition scores
3 Mean566.4 (SD56.7) Modified FSRP
(omitted age)
*****
Dregan
(2013)
8780 (men 3951, women 4829) Change in cog-
nition scores
4 50+ Mean562.5 Modified FSRP
(LVH excluded) and
Framingham CVD
model
*******
Kaffashian
(2011)
4827 (men 3486, women 1341) Change in cog-
nition scores
10 Mean555 (SD56)
Range535 to 55
Framingham CVD
model
*******
Kaffashian
(2013)
CVD and CAIDE risk model
n54374 (men 3162, women
1212) FSRP and CAIDE risk
model n55157 (men 3651,
women 1506)
Change in cog-
nition scores
10 Mean555.6
Range535 to 55
Framingham CVD
model, FSRP and
CAIDE models 1
and 2
******
Kaffashian
(2013)
5810 (men 4153, women 1657) Changes in
cognition
scores
10 Mean555.6
Range535 to 55
FSRP *******
Kelley (2013) 23830 Incident cogni-
tive impairment
4 45+ Mean564.2 FSRP ******
Laughlin
(2011)
985 (men 394, women 591) Changes in
cognition
scores
Median59.8
(IQR52.5, 17.4)
Mean566.8 (SD58.5) Framingham CHD
model
*******
Unverzagt
(2011)
23752 Incident cogni-
tive impairment
Mean54.1 45+ Mean564.3 FSRP ******
Zeki Al
Hazzouri
(2013)
1116 (men 453, women 663) Dementia and
CIND inci-
dence and
change in cog-
nition scores
10 Mean570 Range560
to 101
Framingham CVD
model
*******
Studies examining the CAIDE risk models
Exalto (2013) 9480 Dementia inci-
dence
Mean 536.1 Mean (SD)546.1 (4.3)
Range540 to 55
CAIDE Model 1 plus
additional risk fac-
tors
******
Kivipelto
(2006)
1409 (men 534, women 875) Dementia inci-
dence
20 Mean (SD)550.4 (6.0)
Range539 to 64
CAIDE Model 1 and
CAIDE Model 2
******
Reijmer
(2011)
322 Cognitive
impairment
15 Mean (SD)555.9 (3.7)
Range550 to 64
CAIDE Model 1 ********
Reitz (2010) 1051 AD incidence Mean (SD)54.0 (1.4) 65+ Mean (SD)575.7
(6.3)
Modified CAIDE
Model 2.
********
Virta (2013) 2165 (men 1107, women 1058) Moderate to
severe cogni-
tive impairment
Mean (SD)522.6
(2.3)
65+ Mean (SD)551.7
(6.1)
Modified CAIDE
Model 1 and CAIDE
Model 2
******
Studies examining other cardiovascular risk models
Carmasin
(2014)
435 (men 106, women 329) Change in cog-
nitive test
scores
2.5 Mean (SD)566.8 (9.0) Vascular risk factor
index
****
Elkins (2004) 3832 Changes in
cognitive test
scores
5 65+ CHS Stroke risk
model
********
Klages (2005) 223 AD or VCI inci-
dence
5 65+ Vascularity Index
model
********
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years follow-up [10] and 0.75 (model 1) over 36 years follow-up [11]). One study
added additional risk factors to CAIDE model 1 including central obesity,
depressed mood, diabetes mellitus, head trauma, poor lung function and
smoking, but these variables did not significantly improve predictive accuracy
[11]. The vascular index model, incorporating history of stroke, transient
ischaemic stack, heart attack and diabetes, smoking, use of hypertensive
medications and BP, predicted incident dementia with different accuracy
depending on follow-up time (AUC 0.67 for 20 years and 0.74 for 10 years) [19].
The vascular index described in the Gothenburg H-70 cohort that incorporates
fourteen different variables including hypertension, BMI, cholesterol, dizziness,
calf pain, chest pain, second heart sound abnormal, aortic calcification,
pulmonary congestion, t-wave abnormalities, atrial fibrillation, sinus tachycardia,
diabetes and angina pectoris had low discriminative accuracy for predicting
dementia over 20 years (AUC 0.67) [24]. The remaining studies where dementia
was an outcome did not report prognostic performance indices [22, 23, 25, 26].
The Framingham cardiovascular risk models and cognitive
decline
Four studies used the Framingham CVD model [7, 8, 15, 22], six studies used the
Framingham stroke model [7–9, 16, 17, 21] and one study used the Framingham
CHD model [27]. Calculation of the Framingham stroke risk score was slightly
modified in two studies; one omitted age [21] and the other omitted left
ventricular hypertrophy (LVH) [8]. All studies found higher Framingham risk
scores (i.e., CVD, CHD and stroke) to be associated with an increased risk of
future cognitive decline [7–9, 15, 21, 22, 27] or cognitive impairment [16, 17, 22].
Table 1. Cont.
Author Follow- up sample (sex) Outcome Follow-up (yrs) Baseline age (yrs) CV risk model
Quality
(Newcastle-
Ottawa Scale)
Mitniski
(2006)
380 Dementia inci-
dence
20 75 Vascular index ******
Qiu (2010) 1270 (men 316, women 954) Dementia inci-
dence
Mean: 5.1 75+ Mean (SD)581.5
(5.0)
Vascular risk profile,
Atherosclerotic risk
profile and
Hypoperfusion risk
profile
********
Reis (2013) 2932 (men 1308, women 1624) Changes in
cognition
scores
25 Range518 to 30 Ideal cardiovascular
metrics
********
Whitmer
(2005)
8845 (men 4094, women 4751) Dementia inci-
dence
Mean526.7 Mean542 Composite score
based on 4 vari-
ables
********
The Newcastle-Ottawa Scale assesses selection, comparability and outcome criteria, with a maximum possible score of nine stars for each study.
Abbreviations: AD, Alzheimer’s disease; CAIDE, Cardiovascular Risk Factors, Aging and Dementia; CIND, cognitive impairment no dementia; CHD,
coronary heart disease; CHS, Cardiovascular Health Study; CVD, cardiovascular disease; FSRP, Framingham Stroke Risk Profile; IQR, inter-quartile range;
LVH, left-ventricular hypertrophy; SD, standard deviation; VCI, vascular cognitive impairment.
doi:10.1371/journal.pone.0114431.t001
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Studies differed as to which cognitive abilities were associated with cardiovascular
or stroke risk. While some studies found significant associations across all
cognitive domains tested, others found the association to be present only for
certain cognitive domains including verbal fluency [21] and reasoning [15]. When
stratified by sex, two studies found sex-specific associations (women [27] or men
[15] only), although the association only in women may have been due to
selective attrition of men with greater levels of cognitive decline [27].
The CAIDE models and cognitive decline
Two studies examining the CAIDE models had incident cognitive impairment as
an outcome [28, 29] and one study investigated changes in cognitive test scores
[7]. One study only examined CAIDE model 1 (without ApoE4 status included)
[28] and two studies examined both CAIDE models [7, 29]. The CAIDE models
(both models 1 and 2) were found to be associated with cognitive decline [7] and
incident cognitive impairment [28, 29]. Where specific domains were investigated,
the CAIDE models predicted changes in reasoning, memory, vocabulary,
information processing speed, visuo-construction and abstract reasoning, but not,
language or attention and executive functioning [28], attention, memory,
orientation or abstraction [29]. One study that compared the CAIDE models with
the Framingham CVD model and the Framingham stroke risk model concluded
that all of the models predicted cognitive decline, but the Framingham models
were significantly better than the CAIDE models for predicting changes in
semantic fluency and global cognition [7]. One study examined the prognostic
performance of the CAIDE models in relation to incident cognitive impairment
and found moderate predictive accuracy (CAIDE model 1 AUC 0.74 and CAIDE
model 2 AUC 0.75) [29].
Other cardiovascular risk models and cognitive decline
Seven studies adopted nine other cardiovascular risk prediction models
[18–20, 24–26, 30] (these include those examining both cognitive changes and
dementia incidence as outcomes). All of these risk models included a measure of
BP and eight included a measure of glucose level or diabetes status as well as other
variables such as physical activity, cholesterol levels and a history of CVD
(Table 2). The number of variables incorporated into the cardiovascular risk
models ranged from three to fifteen. All models examined showed significant
positive associations with future cognitive decline including measures of
processing speed, psychomotor speed, executive function and verbal memory
[18, 20, 30].
Discussion
This systematic review of longitudinal population-based studies found that a
wide-variety of CVD risk prediction models have been associated with cognitive
Cardiovascular Risk Models and Cognition: A Systematic Review
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decline or future risk of cognitive impairment or dementia. There was however,
large variability in studies with regard to the cognitive domains tested and the
pattern of associations. Some studies observed differences across all cognitive
domains including memory, non-memory and global cognitive function, whilst
others only observed significant associations for specific cognitive domains such
as reasoning and vocabulary. In the few studies that tested prognostic
performance [10, 11, 24, 29] predictive accuracy for incident dementia were found
Table 2. The different cardiovascular risk models and the variables included.
Cardiovascular risk
model
Variables included
Framingham cardiovas-
cular risk models
Framingham CVD
model
Age, total cholesterol, HDL cholesterol, systolic blood pressure if not treated,
systolic blood pressure if treated, current smoker and diabetes.
FSRP Age, systolic blood pressure, antihypertensive therapy, current smoker, diabetes,
CVD, atrial fibrillation and LVH.
Framingham CHD
model
Age, total cholesterol or LDL cholesterol, HDL cholesterol, systolic and diastolic
blood pressure, current smoker and diabetes.
CAIDE risk models
CAIDE Model 1 Age, total cholesterol, systolic blood pressure, BMI, sex, education and physical
activity.
CAIDE Model 2 Age, total cholesterol, systolic blood pressure, BMI, sex, education, physical
activity and ApoE4 status.
Other cardiovascular
risk models
Vascular risk factor
index
Diabetes, CVD, blood pressure, history of a heart attack, angina, circulation
problems and history of stroke.
CHS Stroke risk model Age, systolic blood pressure, diabetes mellitus, impaired fasting glucose, atrial
fibrillation, LVH, sex, history of heart disease, creatinine level and 15ft walk time.
Vascularity index model History of stroke, transient ischaemic attack, heart attack, diabetes, smoking, use
of antihypertensive medications and sitting systolic blood pressure.
Vascular index Dizziness, calf pain, chest pain, second heart sound abnormal, aortic calcification,
pulmonary congestion, t-wave abnormalities, atrial fibrillation, sinus tachycardia,
diabetes, hypertension, treated hypertension, angina pectoris, BMI, cholesterol.
Vascular risk profile Systolic blood pressure, diastolic blood pressure, pulse pressure, diabetes/pre-
diabetes, stroke and heart failure.
Atherosclerotic risk pro-
file
Systolic blood pressure, diabetes/pre-diabetes and stroke.
Hypoperfusion risk pro-
file
Diastolic blood pressure, pulse pressure and heart failure.
Ideal cardiovascular
metrics
BMI, diet score, smoking, physical activity, total cholesterol, blood pressure and
fasting glucose.
Composite vascular
score
Hypertension, smoking, cholesterol and diabetes.
Abbreviations: ApoE, Apolipoprotein E; BMI, body mass index; CAIDE, Cardiovascular Risk Factors, Aging
and Dementia, CHD, coronary heart disease; CHS, cardiovascular health study; CVD, cardiovascular
disease; FSRP, Framingham stroke risk profile; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
LVH, left ventricular hypertrophy.
doi:10.1371/journal.pone.0114431.t002
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to be moderate (AUC range 0.74 to 0.78) across different CVD risk prediction
models.
The main strength of this study is that it is the first systematic review
undertaken to summarise current evidence on the association between CVD risk
predictions models and cognitive decline and dementia. The review is wide in
scope and included studies that examined dementia incidence as well as changes
in cognitive test scores as outcomes over time. There are some limitations. Only
studies published in English were included. Also, the included studies were
characterised by large variability in study design (e.g., follow-up time, sample size)
as well as the risk model evaluated (and modifications made to calculating the risk
score) and the outcome measures used. Therefore it was not possible to synthesise
the results into a meta-analysis. In order to compare studies, better consistency of
methodological approaches is needed.
Each model in this review included different risk factors selected to accurately
predict the outcome they were originally designed for including: CVD, stroke,
CHD, overall cardiovascular health, AD, depression and all-cause dementia. Apart
from the CAIDE, none of the vascular index, the composite vascular model and
the vascularity index models, were designed to predict changes in cognitive
function or incident dementia. What risk factors should be included to predict
future cognitive decline and dementia requires the rationale for their inclusion in
a risk score as well as further empirical studies testing the best combination of
predictors from a wide-range of well-justified risk factors for different outcomes.
The results here suggest that the Framingham models could be a good starting
point for future validation analysis.
All CVD risk models included BP and most included cholesterol, diabetes
mellitus and smoking status. Each of these factors has been associated with
cognitive decline and dementia [6]. However, CVD and its risk factors rarely
occur in isolation, particularly in older aged individuals where disease related co-
morbidity and multi-morbidity is high [31, 32]. In addition, an advantage of such
CVD risk models is that they are typically calculated in clinical settings and could
be used not only to ascertain an individual’s vascular health status, but as
suggested by the results of this review, may also be useful to inform clinicians of
the individual’s risk of future cognitive decline and dementia. Clinicians may then
able to adopt similar CVD risk reducing strategies that will not only benefit
cardiovascular health, but also future cognitive wellbeing. The advantage of this is
that although clinicians may not be acutely aware of cognitive intervention
strategies, they are well versed in cardiovascular health risk reduction strategies
e.g., reducing smoking, alcohol and BP management.
Across the different CVD risk models associations with cognitive function
varied depending on the risk score calculated, outcome tested and participant
gender. Generally the different CVD risk models were associated with at least one
cognitive measure over time or incident dementia. Significant associations were
found between CVD risk models and specific cognitive measures for global,
memory and non-memory measures including category fluency, executive
functioning, reasoning, phonemic fluency, semantic fluency, vocabulary, infor-
Cardiovascular Risk Models and Cognition: A Systematic Review
PLOS ONE | DOI:10.1371/journal.pone.0114431 December 5, 2014 10 / 14
mation processing speed and visuo-construction performance. Yet, there was
variability between studies in terms of associations with specific domain measure
e.g., the English Longitudinal Study of Ageing found a significant association
between the Framingham stroke risk model and the Framingham CVD model and
memory decline [8], whereas, the Whitehall II Study did not find a significant
association between the Framingham risk models and changes in memory
[7, 9, 15]. Further, a comparative study of the CAIDE models with the
Framingham stroke risk model and Framingham CVD models found a stronger
association between changes in global cognition and semantic fluency and
Framingham models compared to the CAIDE models [7]. The study suggested
that as the CAIDE models include education they may be better suited to its’
original purpose for detecting dementia risk rather than predicting cognitive
decline, as education was not found to be associated with 10-year cognitive
decline in the original study. The combination of cardiovascular risk variables in
the Framingham models may have led to the greater association with cognitive
decline [7].
The studies examined in this review had very different follow-up times (range:
2.5 [30] to 36.1 years [11]). This shows that there is potentially a long time to
intervene and target vascular risk factors to reduce risk of future cognitive decline
or dementia. Further, it has been well established that vascular risk factors have
different magnitude and even direction of associations with dementia risk
depending on whether they are examined at mid or later-life. For instance, high
BP has been found to be positively associated with cognitive decline when
measured at mid-life, but has been found to have a potentially beneficial effect
towards cognitive decline in the oldest-old, those aged 85 years and older [33].
However, it is uncertain whether this is reverse causation as BP may be lower in
those who experience greater cognitive decline due to underlying dementia
pathology [34]. In this review, no study examined the association between
cardiovascular risk and cognitive changes in the oldest-old, but cardiovascular risk
models were found to be associated with cognitive decline in the older population
(four studies were conducted in populations with a mean age 70 years and older).
This suggests that determining cardiovascular risk even in later-life may be useful
for understanding cognitive decline or dementia risk.
Only four studies have calculated and compared model prognostic perfor-
mance; three studies tested this for the CAIDE models [10, 11, 29] and one study
tested this for a non-Framingham vascular risk model [24]. The results were
mixed. The CAIDE model was found to have higher accuracy for predicting
dementia compared to a vascular index model [11, 24]. The vascular index and
the CAIDE models only share three variables including: systolic BP, BMI and
cholesterol. The vascular index contains additional variables related to
cardiovascular history and history of other diseases (e.g., angina pectoris and
diabetes); whereas, the CAIDE models contain additional variables related to
demographic, lifestyle and genetic factors (age, sex, education, physical activity
and ApoE4). These results suggest that a combination of both cardiovascular,
lifestyle and genetic factors may potentially be useful for dementia risk prediction.
Cardiovascular Risk Models and Cognition: A Systematic Review
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In contrast, the predictive accuracy of the Framingham models has not been
examined in relation to incident dementia or cognitive impairment. Therefore, it
remains unknown how predictive the Framingham models are for cognitive
changes and dementia over time. Further research is needed to compare the
predictive accuracy of the Framingham and non-Framingham models. This is
especially important; as compared to other dementia risk prediction models the
Framingham models contain variables that are already easily collectable within
clinical practice (for a systematic review of dementia specific risk models see [35]).
Conclusion
Overall, a strong positive association was observed between the different vascular
risk models and future cognitive decline or incident cognitive impairment or
dementia. Importantly, such scores are easily obtainable in clinical and research
settings and may be useful for identifying those individuals in a population who
are at highest risk of future cognitive decline and dementia. However, before
recommendations can be made as to which model works best and whether any
can be recommended for use within a cognitive/dementia risk prediction
framework further validation and comparative work is needed. This is particularly
important with regard to testing model prognostic performance in different
samples (e.g., population-based vs. clinical) with different ethnic, health and
socio-demographic characteristics (e.g., age and sex).
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